Anita Meiklejohn, Ph.D., focuses her practice on patent prosecution, validity and infringement opinions, and litigation in the area of biotechnology.
She previously worked as an associate and technology specialist with Fish. Anita also has technical experience as a post-doctoral fellow at Harvard University in the department of biochemistry and molecular biology.
Prosecution of patent applications in all areas of molecular biology and biochemistry including genomics, proteomics, polymorphism identification and analysis, recombinant nucleic acid and protein products, immunology including engineered monoclonal antibodies, transgenic animals, virology and vaccines. Special areas of expertise include inventions involving cell surface receptors, transcription factors, immunoassays, cytokines, nucleic acid probes, AIDS therapies, molecular design and modeling of drugs, rational drug design, and the use of combinatorial techniques in drug screening.
Participated in patent infringement litigation on behalf of Genentech before the U.S. International Trade Commission (human growth hormone).